Eli Lilly
3,933 hedge funds and large institutions have $689B invested in Eli Lilly in 2025 Q1 according to their latest regulatory filings, with 250 funds opening new positions, 1,803 increasing their positions, 1,416 reducing their positions, and 170 closing their positions.
211% more capital inflows, than outflows
Capital inflows: $68B | Capital outflows: $21.9B
47% more first-time investments, than exits
New positions opened: 250 | Existing positions closed: 170
27% more repeat investments, than reductions
Existing positions increased: 1,803 | Existing positions reduced: 1,416
19% more funds holding in top 10
Funds holding in top 10: 337 → 401 (+64)
5.91% more ownership
Funds ownership: 82.27% → 88.18% (+5.9%)
0% more funds holding
Funds holding: 3,919 → 3,933 (+14)
7% less call options, than puts
Call options by funds: $9.22B | Put options by funds: $9.9B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$41.6B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$4.15B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.14B |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$951M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$901M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$2.25B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.72B |
| 3 |
Primecap Management
Pasadena,
California
|
-$1.64B |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.44B |
| 5 |
JP Morgan Chase
New York
|
-$1.19B |
LLY Hedge Fund Activity: Q1 2025 in Review
3,933 of the 7,486 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2025, worth a combined $689B — up 14% from $603B a quarter earlier.
Buyers outnumbered sellers: 250 funds opened new LLY positions and 170 closed out — a net gain of 80 holders — while 1,803 added to existing stakes and 1,416 trimmed.
The largest buyer was PNC Financial Services Group, adding an estimated $41.6B. The largest seller was GQG Partners, cutting an estimated $2.25B.
- 3,933 institutional investors held Eli Lilly (LLY) as of Q1 2025, up from 3,919 in Q4 2024.
- Funds reported $689B of Eli Lilly stock for Q1 2025, up 14% quarter-over-quarter.
- 250 funds opened new Eli Lilly positions in Q1 2025 and 170 closed out, a net change of +80 holders.
- The largest Eli Lilly buyer in Q1 2025 was PNC Financial Services Group, an estimated $41.6B added.
- The largest Eli Lilly seller in Q1 2025 was GQG Partners, an estimated $2.25B sold.
Based on aggregated 13F filings for Q1 2025.